KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 190 filers reported holding KITE PHARMA INC in Q4 2015. The put-call ratio across all filers is 0.66 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $6,616,000 | +85.5% | 36,796 | +6.9% | 0.06% | +69.4% |
| Q2 2017 | $3,567,000 | +40.5% | 34,406 | +6.4% | 0.04% | +33.3% |
| Q1 2017 | $2,538,000 | +41.9% | 32,337 | -18.9% | 0.03% | +35.0% |
| Q4 2016 | $1,788,000 | -12.2% | 39,880 | +9.4% | 0.02% | -28.6% |
| Q3 2016 | $2,036,000 | -4.9% | 36,452 | -14.8% | 0.03% | 0.0% |
| Q2 2016 | $2,140,000 | +13.6% | 42,799 | +4.3% | 0.03% | +7.7% |
| Q1 2016 | $1,884,000 | -26.0% | 41,031 | -0.7% | 0.03% | -16.1% |
| Q4 2015 | $2,545,000 | +21.9% | 41,304 | +10.2% | 0.03% | +6.9% |
| Q3 2015 | $2,088,000 | -10.0% | 37,497 | -1.4% | 0.03% | -9.4% |
| Q2 2015 | $2,320,000 | +22.9% | 38,044 | +16.3% | 0.03% | +45.5% |
| Q1 2015 | $1,887,000 | +19.4% | 32,715 | +19.3% | 0.02% | +22.2% |
| Q4 2014 | $1,581,000 | – | 27,413 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $108,260,000 | 37.66% |
| Coastal Bridge Advisors, LLC | 250,040 | $11,479,000 | 8.02% |
| RTW INVESTMENTS, LP | 343,503 | $15,770,000 | 5.72% |
| DSAM Partners (London) Ltd | 256,550 | $11,778,000 | 5.26% |
| Silver Rock Financial LLC | 109,199 | $5,013,000 | 5.09% |
| Casdin Capital, LLC | 75,000 | $3,443,000 | 3.95% |
| EcoR1 Capital, LLC | 150,000 | $6,887,000 | 2.41% |
| Vivo Capital, LLC | 193,193 | $8,869,000 | 2.22% |
| BB BIOTECH AG | 750,000 | $34,433,000 | 1.37% |
| MENORA MIVTACHIM HOLDINGS LTD. | 494,988 | $22,725,000 | 1.36% |